MeiraGTx Holdings plc (MGTX) Prices 5M Share Offering at $12.85/Sh

Go back to MeiraGTx Holdings plc (MGTX) Prices 5M Share Offering at $12.85/Sh

After-Hours Movers 11/18: (APVO) (CORT) (SONO) Higher; (WRN) (MGTX) (GPRO) Lower (more...)

November 18, 2020 5:42 PM EST

Today's After-Hours Movers

Aptevo Therapeutics (NASDAQ: APVO) 34.5% HIGHER; holder Tang Capital disclosed: On November 18, 2020, the Reporting Persons submitted a bid letter to the Board of Directors of the Issuer offering to acquire the remaining common stock of the Issuer that Tang Capital Partners, LP does not already own for a price of $50.00 per share in cash. A copy of the bid letter is attached as Exhibit 2 and incorporated by reference in this Item 4 in its entirety.

Corcept Therapeutics (NASDAQ:... More

After-Hours Movers 11/18: (APVO) (CORT) (SONO) Higher; (WRN) (MGTX) (GPRO) Lower (more...)

November 18, 2020 5:42 PM EST

Today's After-Hours Movers

Aptevo Therapeutics (NASDAQ: APVO) 34.5% HIGHER; holder Tang Capital disclosed: On November 18, 2020, the Reporting Persons submitted a bid letter to the Board of Directors of the Issuer offering to acquire the remaining common stock of the Issuer that Tang Capital Partners, LP does not already own for a price of $50.00 per share in cash. A copy of the bid letter is attached as Exhibit 2 and incorporated by reference in this Item 4 in its entirety.

Corcept Therapeutics (NASDAQ:... More

MeiraGTx Holdings plc (MGTX) Announces Proposed 5M Share Public Offering of Ordinary Shares

November 18, 2020 4:25 PM EST

MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has commenced an underwritten public offering of 5,000,000 of its ordinary shares. In connection with the offering, MeiraGTx intends to grant the underwriters a 30-day option to purchase up to an additional 750,000 of its... More

MeiraGTx Holdings plc (MGTX) Announces Proposed 5M Share Public Offering of Ordinary Shares

November 18, 2020 4:25 PM EST

MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it has commenced an underwritten public offering of 5,000,000 of its ordinary shares. In connection with the offering, MeiraGTx intends to grant the underwriters a 30-day option to purchase up to an additional 750,000 of its... More